← All organizations

Instituto Universitario de Oftalmobiología Aplicada

Academic/HospitalWebsite ↗

Also known as: Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Jun 30, 2025

Timeline

2000s

Jan 1, 2009
Instituto Universitario de Oftalmobiología Aplicada— Founded

Drugs by trial phase (10 distinct, 9 trials)

Phase 4 (1 own, 0 via acquisition)

cyclosporine

Phase 3 (4 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

allogeneic adipose derived mesenchymal stem cell

Phase 1 (1 own, 0 via acquisition)

bosentan

Other trials (3 own, 0 via acquisition)

Indications

Studied for

Recent trials (9)

NCT06905834CollaboratorPhase 2Jun 30, 2025
NCT05290727Lead sponsorN/AMar 1, 2022
NCT04492878Lead sponsorPhase 4Feb 4, 2020
NCT04068272CollaboratorPhase 1Sep 7, 2019
NCT02051023Lead sponsorPhase 3Feb 1, 2014
NCT01716026Lead sponsorPhase 3Oct 1, 2012
NCT00970957Lead sponsorPhase 3Sep 1, 2009
NCT00967850Lead sponsorPhase 3Apr 1, 2008
NCT00309192Lead sponsorPhase 3Apr 1, 2006

Details

Founded: Valladolid, ES Jan 1, 2009
Last known activity: Jun 30, 2025